Official Title
Administration of Systemic Corticosteroids Among Critically Ill Patients With COVID-19: Electronic Survey (ASAP-C Study)
Brief Summary

Administration of systemic corticosteroids for patients with severe forms of severe acute respiratory syndrome(SARS-Co-2) infection are recommended by several guidelines. In the very beginning of SARS-Co-2 pandemic the early recommendation by professional organization was against routine use of corticosteroids for patients with coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS), despite previous data and clinical practice for patients with refractory or severe form of ARDS.

Detailed Description

Administration of systemic corticosteroids for patients with severe forms of SARS-Co-2
infection are recommended by several guidelines. In the very beginning of SARS-Co-2 pandemic
the early recommendation by professional organization was against routine use of
corticosteroids for patients with coronavirus disease 2019 (COVID-19) ARDS, despite previous
data and clinical practice for patients with refractory or severe form of ARDS. But at the
latest after publication of RECOVERY trial (Randomized Evaluation of Covid-19 Therapy, July
2020) and ensued metaanalysis of World Health Organization (WHO) working group, the routine
administration of systemic corticosteroids was revisited. However, there are ongoing critical
debate of the evidence regarding the dose, administration, timing and type of corticosteroids
and ongoing randomized controlled trial (RCT) are challenging the recommendation of 6 mg of
dexamethasone for all patients with severe form of COVID-19. The dynamic of COVID-19 surges,
flip-flop of official recommendations within very short period of time and ongoing critical
debate could be with possible variations of daily clinical practice regarding using systemic
corticosteroids. In an electronic evaluation form that will be send to European Society of
Intensive Care (ESICM) Members. The electronic survey will contain 10 question. In the
questionnaire the participants will have to describe their routine clinical practice
regarding administration of systemic corticosteroids among patients with COVID-19 ARDS.

Recruiting
Severe Covid-19

Other: questionnaire

Members of European Society of Intensive Care will obtain an electronic survey considering their routine clinical practice regarding the administration of systemic corticosteroids among patients with COVID-19 ARDS
Other Name: survey

Eligibility Criteria

Inclusion Criteria:

- Members of European Society of Intensive Care

Exclusion Criteria:

- not members of European Society of Intensive Care

Eligibility Gender
All
Eligibility Age
Minimum: 28 Days ~ Maximum: 100 Years
Countries
Czechia
Locations

University Hospital Brno
Brno, Czechia

Investigator: Jan Malaska, MD. Ph.D.
Contact: 532232009
jan.malaska@gmail.com

Contacts

Jan Malaska, MD., Ph.D
532232009 - 00420
jan.malaska@gmail.com

Jozef Klučka, assoc.Prof.MD, Ph.D
532234696
klucka.jozef@fnbrno.cz

Jan Malaska, MD., Ph.D, Principal Investigator
University Hospital Brno

Brno University Hospital
NCT Number
MeSH Terms
COVID-19